.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Chubb
Colorcon
Argus Health
Accenture
Daiichi Sankyo
Queensland Health
Baxter
Dow
Moodys

Generated: December 13, 2017

DrugPatentWatch Database Preview

Drug Master Files for: TOBRAMYCIN SULFATE

« Back to Dashboard


DMF No. Status Type Submission Date Holder Subject
7578III7/7/1988PHARMACHIM ECONOMIC CORPTOBRAMYCIN BASE
12128III9/12/1996GUANGDONG QINGYUAN NEW NORTH RIVER PHARMACEUTICAL CO LTDTOBRAMYCIN
12151III10/1/1996GUANGDONG QINGYUAN NEW NORTH RIVER PHARMACEUTICAL CO LTDMANUFACTURING FACILITIES FOR TOBRAMYCIN PHARMACEUTICAL CO., LTD.
13513III9/1/1998LILLY RESEARCH LABORATORIESTOBRAMYCIN SULFATE
13713AII9/1/1998TEVA PHARMACEUTICAL INDUSTRIES LTDTOBRAMYCIN
13739III9/1/1998PHARMACHIM ECONOMIC CORPTOBRAMYCIN
13770III9/1/1998ZHEJIANG HISUN PHARMACEUTICAL CO LTDTOBRAMYCIN
13774AII9/1/1998CHONGQING DAXIN PHARMACEUTICAL CO LTDTOBRAMYCIN USP
15021AII9/12/2000XELLIA PHARMACEUTICALS APSTOBRAMYCIN SULPHATE, NON-STERILE BULK
15629AII9/17/2001XELLIA PHARMACEUTICALS APSTOBRAMYCIN SULPHATE, USP STERILE BULK
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Cipla
Queensland Health
Deloitte
US Army
Fuji
Healthtrust
US Department of Justice
Harvard Business School
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot